SZSE:300683 (China)
Â
Class A
Â¥
24.36
(+1.2%)
May 24
Business Description
Wuhan Hiteck Biological Pharma Co Ltd
ISIN : CNE1000034C5
Share Class Description:
SZSE:300683: Class ACompare
Compare
Traded in other countries / regions
300683.China IPO Date
2017-08-08Description
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 17 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.36 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.91 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.7 | |||||
| 3-Year EBITDA Growth Rate | -99.6 | |||||
| 3-Year EPS without NRI Growth Rate | -40.2 | |||||
| 3-Year FCF Growth Rate | 0.8 | |||||
| 3-Year Book Growth Rate | 4.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.17 | |||||
| 9-Day RSI | 41.71 | |||||
| 14-Day RSI | 45.15 | |||||
| 6-1 Month Momentum % | -37.59 | |||||
| 12-1 Month Momentum % | -35.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.73 | |||||
| Quick Ratio | 4.35 | |||||
| Cash Ratio | 3.37 | |||||
| Days Inventory | 142.26 | |||||
| Days Sales Outstanding | 33.25 | |||||
| Days Payable | 49.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.2 | |||||
| Shareholder Yield % | 1.3 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.84 | |||||
| Operating Margin % | -23.82 | |||||
| Net Margin % | -22.82 | |||||
| FCF Margin % | -16.55 | |||||
| ROE % | -5.35 | |||||
| ROA % | -4.59 | |||||
| ROIC % | -6.92 | |||||
| ROC (Joel Greenblatt) % | -23.11 | |||||
| ROCE % | -6.38 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 31.23 | |||||
| PS Ratio | 5.8 | |||||
| PB Ratio | 1.3 | |||||
| Price-to-Tangible-Book | 1.67 | |||||
| Price-to-Operating-Cash-Flow | 94.79 | |||||
| EV-to-EBIT | -12.7 | |||||
| EV-to-EBITDA | -12.7 | |||||
| EV-to-Revenue | 3.63 | |||||
| EV-to-FCF | -24.8 | |||||
| Price-to-Projected-FCF | 3.31 | |||||
| Price-to-Net-Current-Asset-Value | 3.3 | |||||
| Price-to-Net-Cash | 5.84 | |||||
| Earnings Yield (Greenblatt) % | -7.87 | |||||
| FCF Yield % | -3.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wuhan Hiteck Biological Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 595.536 | ||
| EPS (TTM) (Â¥) | -1.044 | ||
| Beta | 1.21 | ||
| Volatility % | 56.78 | ||
| 14-Day RSI | 45.15 | ||
| 14-Day ATR (Â¥) | 1.435183 | ||
| 20-Day SMA (Â¥) | 25.6685 | ||
| 12-1 Month Momentum % | -35.09 | ||
| 52-Week Range (Â¥) | 18.8 - 51.64 | ||
| Shares Outstanding (Mil) | 130.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wuhan Hiteck Biological Pharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wuhan Hiteck Biological Pharma Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Wuhan Hiteck Biological Pharma Co Ltd Frequently Asked Questions
What is Wuhan Hiteck Biological Pharma Co Ltd(SZSE:300683)'s stock price today?
The current price of SZSE:300683 is ¥24.36. The 52 week high of SZSE:300683 is ¥51.64 and 52 week low is ¥18.80.
When is next earnings date of Wuhan Hiteck Biological Pharma Co Ltd(SZSE:300683)?
The next earnings date of Wuhan Hiteck Biological Pharma Co Ltd(SZSE:300683) is .
Does Wuhan Hiteck Biological Pharma Co Ltd(SZSE:300683) pay dividends? If so, how much?
Wuhan Hiteck Biological Pharma Co Ltd(SZSE:300683) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers